2,313 research outputs found
PCV17 COST EFFECTIVENESS ANALYSIS OF ROSUVASTATIN 10 MG VS. ATORVASTATIN 20 MG FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
Adherence to Mediterranean Diet Pattern among Spanish Adults Attending a Medical Centre: Nondiabetic Subjects and Type 1 and 2 Diabetic Patients.
Objective. To identify adherence to Mediterranean diet among two groups of Spanish adults: diabetic patients and nondiabetic subjects. Methods. Adherence to Mediterranean diet was measured by a 14-item screener (scale: 0–14; =5: low, 6–9: moderate, and =10: high) in 351 volunteers. Results. Mean age was 50.97±12.58 in nondiabetics (n=154) and 59.50±13.34 in diabetics (n = 197). The whole sample scored 8.77 ± 1.82. Score was 9.19 ± 1.84 in nondiabetic females (n = 58) and 8.15 ± 1.79 in diabetic females (n = 85) (p = 0 003), due to lower consumption of olive oil (p = 0 005) and nuts (p = 0 000). Type 2 diabetic males (n = 79; 8.76 ± 1.88) consumed less olive oil than healthy males (n = 28; 9.36 ± 1.59) (p = 0 046). Up to 30-year-old nondiabetics scored lower than more than 60-year-old nondiabetics (8.40 ± 1.5 versus 9.74 ± 2.03; p = 0 047). The youngest ate less olive oil (p = 0 002) and more pastries (p = 0 007). Conclusions. The sample presented moderate adherence to Mediterranean diet in all subgroups. Scientific evidence about the benefits of Mediterranean diet, olive oil, and nuts supports the recommendation to increase consumption of olive oil and nuts in diabetic women and of daily olive oil in type 2 diabetic men, reducing consumption of red meat, butter, and pastries, and to promote Mediterranean diet among the youngest of the sample studie
Effect of nitrogen and potassium fertilizers on melon plant productivity
The objective of this investigation was to evaluate the effect of different doses of nitrogen and potassium fertilizers on some production parameters of melon plants. The experiment was carried out in San Roque, which is 24 km from the city of Concepción, Paraguay, at the coordinates 57°14´10.29´´ South and 23°19´12.05´´ West. The study design was the completely randomized block with three replications in a split plot scheme 4 x 4. The dose used in the main plot was of N (0, 50, 100 and 150 kg ha-1) and in the sub-plot, K (0, 95, 190 and 285 kg ha-1). A light harrow was carried out to prepare the soil, seedlings were produced in 1500 cm3 pots of 60-micron thickness and the transplant was carried out when the seedlings had between 4 and 6 true leaves at 30 days after planting. Urea with 45% N was used as the source of nitrogen and potassium chloride 60% was used as the source of potassium. Fertilisation was carried out in September 2017 on two occasions: at 15 and 30 days after transplanting. The spacing used was of 1.5 m between rows and 1.5 m between plants, giving a total of 4356 plants ha-1. Harvesting began 90 days after planting and was carried out three times as the fruits reached commercial ripeness. The variables that were measured were average fruit weight (AFW), total soluble solids (TSS), polar diameter (PD), equatorial diameter (ED), fruit weight per plant (FWP). The data of the evaluated variables were subjected to the analysis of variance using the Fisher test where significant differences were found in: AFW, TSS, PD, ED and FWP. Subsequently, the regression analysis was performed (AFW, TSS and PD) and response surface (ED and FWP). The dose combination that produced the best values for equatorial diameter and fruit weight per plant was 71.9495 kg ha-1 of N and 160.554 kg ha-1 of K, 77.5921 kg ha-1 of N and 147.369 kg ha-1 of K, respectively. 
Risk assessment and suicide by patients with schizophrenia in secondary mental healthcare: a case-control study
Objectives: To investigate the role of risk assessment in predicting suicide in patients with schizophrenia spectrum disorders (SSDs) receiving secondary mental healthcare. We postulated that risk assessment plays a limited role in predicting suicide in these patients. Design: Retrospective case–control study. Setting: Anonymised electronic mental health record data from the South London and Maudsley National Health Service (NHS) Foundation Trust (SLaM) (London, UK) linked with national mortality data. Participants: In 242 227 SLaM service users up to 31 December 2013, 635 suicides were identified. 96 (15.1%) had a SSD diagnosis. Those who died before 1 January 2007 (n=25) were removed from the analyses. Thus, 71 participants with SSD who died from suicide over the study period (cases) were compared with 355 controls. Main outcome measure: Risk of suicide in relation to risk assessment ratings. Results: Cases were younger at first contact with services (mean±SD 34.5±12.6 vs 39.2±15.2) and with a higher preponderance of males (OR=2.07, 95% CI 1.18 to 3.65, p=0.01) than controls. Also, suicide occurred within 10 days after last contact with services in half of cases, with the most common suicide methods being hanging (14) and jumping (13). Cases were more likely to have the following ‘risk assessment’ items previously recorded: suicidal history (OR=4.42, 95% CI 2.01 to 9.65, p<0.001), use of violent method (OR=3.37, 95% CI 1.47 to 7.74, p=0.01), suicidal ideation (OR=3.57, 95% CI 1.40 to 9.07, p=0.01) and recent hospital discharge (OR=2.71, 95% CI 1.17 to 6.28, p=0.04). Multiple regression models predicted only 21.5% of the suicide outcome variance. Conclusions: Predicting suicide in schizophrenia is highly challenging due to the high prevalence of risk factors within this diagnostic group irrespective of outcome, including suicide. Nevertheless, older age at first contact with mental health services and lack of suicidal history and suicidal ideation are useful protective markers indicative of those less likely to end their own lives
Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma
Altres ajuts: This work was supported in part by grants from La Marató TV3 (Exp. 20130710), Deutsche José Carreras Leukämie Stiftung (DJCSL 10R/2016), Fundación Científica Asociación Española Contra el Cáncer (AECC-AIO2017), Fundacion Bancaria 'La Caixa', TerCel (SG/11/2008)Adoptive cell therapy (ACT) with mature T cells modified with a chimeric antigen receptor has demonstrated improved outcome for B-cell malignancies. However, its application for others such as Hodgkin lymphoma remains a clinical challenge. CD30 antigen, expressed in Hodgkin lymphoma cells, is absent in most healthy tissues, representing an ideal target of ACT for this disease. Despite that, efficacy of CD30-chimeric antigen receptor (CAR) T cells for Hodgkin lymphoma remains modest. Here, we have developed and tested a novel CD30-CAR T to improve efficacy of CD30-CAR therapy, using a targeting epitope within the non-cleavable part of CD30 receptor, and memory stem T cells (T) to improve engraftment, persistence and antitumor activity. T cultures were generated and expanded ex vivo and transduced at day 1 or 2 with a lentiviral vector encoding the CD30-CAR. Therapeutic in vivo experiments were performed using NSG mice injected with L540 (sc) or L428 (iv) and treated with CD30-CAR T cells when the tumor was established. CD30-CAR T cells generated and expanded ex vivo, despite CD30 expression and fratricide killing of CD30 + CAR T cells, were not impaired by soluble CD30 and completely eradicated Hodgkin lymphoma in vivo, showing high persistence and long-lasting immunity. In addition, highly enriched CD30-CAR T products confer a survival advantage in vivo, in contrast to more differentiated CAR T cells, with higher tumor infiltration and enhanced antitumor effect. This study supports the use of a refined CD30-CAR T cells with highly enriched T products to improve clinical efficacy of CAR T for Hodgkin lymphoma. We have studied the efficacy of a redesigned CD30-chimeric antigen receptor (CAR) targeting a proximal epitope to enhance the antitumor efficacy. CD30-CAR T cells show potent in vivo antitumor effect in different Hodgkin lymphoma models, and overcome inhibition by soluble CD30. CD30-CAR memory stem T-cell products show long-term persistence, improved tumor homing and long-lasting immunity
Health education in the community pharmacy: controlled in the province of Castellón study.
Introducción: La educación para la salud es una de las actividades que debe realizar el farmacéutico comunitario orientada hacia el paciente. Con el objetivo de conocer la influencia de la educación sanitaria en los pacientes, se realizó un estudio controlado en farmacias comunitarias de la provincia de Castellón.Material y métodos: En el estudio participaron catorce oficinas de farmacia (siete en el grupo control y siete en el grupo intervención). En todas ellas se realizó una encuesta inicial a los pacientes sobre educación para la salud. En las farmacias del grupo intervención se realizaron cinco campañas de educación sanitaria y al finalizar cada campaña los pacientes completaron una encuesta para valorar la educación sanitaria recibida. En las farmacias del grupo control se pasaron las encuestas a los pacientes pero no se realizaron las campañas de educación sanitaria.Resultados y discusión: Los pacientes están significativamente más satisfechos con la formación que reciben en las farmacias que realizan educación sanitaria. Además, se incrementa significativamente la percepción que tiene la población del farmacéutico en la oficina de farmacia como punto de referencia a la hora de ayudar a resolver sus problemas de salud. La educación sanitaria permite que los pacientes reciban formación completa acerca de temas de salud que les preocupan y les proporciona más capacidad para resolverlos por ellos mismos.Introduction: Health education is one of the roles of the community pharmacist.A controlled study of pharmacies in the Spanish province of Castellón was carried out with the aim of determining the influence of health education on the general public.Material and methods: Fourteen pharmacies took part in the study: seven in the group control and seven in the intervention group. An initial survey about health education was conducted among the patients of all fourteen pharmacies. In the pharmacies in the intervention group five campaigns of health education were instigated; after each campaign patients answered a survey to evaluate the health education received. In the pharmacies in the control group the same surveys were carried out without the implementation of any educational campaigns.Results and discussion: Patients of the pharmacies in the intervention group were significantly more satisfied with their level of knowledge about health matters than those in the control other group. In addition, the same patients had a significantly more satisfied with the formation they received in the pharmacies that implemented the educational campaigns. In addition, patients of the pharmacies in the intervention group had a significantly better perception of the pharmacist and of the pharmacy as a reference point with respect to resolving their health problems. Health education informs patients about aspects of health and endows them with the aptitude to make decisions related to their health problems
Prevalence of primary headaches: it is not the behavior, but still we have to pay attention to it!
Treatment of primary membranous nephropathy: where are we now?
In the last 10 years, basic science and clinical research have made important contributions to the understanding and management of primary membranous nephropathy (MN). The identification of antibodies directed against the M-type phospholipase A2 receptor (PLA2R) and thrombospondin type-1 domain-containing 7A protein have added a new perspective on diagnosis, monitoring the immunological activity, predicting prognosis and guiding therapy in patients with primary MN. Mounting evidence suggests that quantification and follow-up of antiPLA2R Abs levels can help in assessing prognosis and evaluate the response to treatment. The kidney disease improving global outcomes guidelines published in 2012 have not been updated. New data on the use of rituximab suggest it should be considered as a potential initial therapy in the treatment of patients with primary MN
Evidence for dark matter in the inner Milky Way
The ubiquitous presence of dark matter in the universe is today a central
tenet in modern cosmology and astrophysics. Ranging from the smallest galaxies
to the observable universe, the evidence for dark matter is compelling in
dwarfs, spiral galaxies, galaxy clusters as well as at cosmological scales.
However, it has been historically difficult to pin down the dark matter
contribution to the total mass density in the Milky Way, particularly in the
innermost regions of the Galaxy and in the solar neighbourhood. Here we present
an up-to-date compilation of Milky Way rotation curve measurements, and compare
it with state-of-the-art baryonic mass distribution models. We show that
current data strongly disfavour baryons as the sole contribution to the
galactic mass budget, even inside the solar circle. Our findings demonstrate
the existence of dark matter in the inner Galaxy while making no assumptions on
its distribution. We anticipate that this result will compel new
model-independent constraints on the dark matter local density and profile,
thus reducing uncertainties on direct and indirect dark matter searches, and
will shed new light on the structure and evolution of the Galaxy.Comment: First submitted version of letter published in Nature Physics on
Febuary 9, 2015:
http://www.nature.com/nphys/journal/vaop/ncurrent/full/nphys3237.htm
- …